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Results: Hospital mortality was 11% (16 patients died). Predictive clinical
factors of in-hospital mortality were: age over 60 years (OR=23.7, P<0.001),
history of COPD (OR=5.04, P=0.006) or stroke (OR=23.7, P<0.001), respira-
tory rate> 25 cycles per minute (OR=18.6, P=0.007) and presence of motor
deficit (OR=7.92, P<0.001) or signs of right heart failure (OR=3.45, P=0.032)
or left ventricular failure (OR=10.41, P <0.001). Predictive echocardiographic
factors of in-hospital mortality were: right ventricular dilatation (OR=1.27,
P=0.011), dilatation of the right atrium (OR=1.37, P=0.003), presence of pul-
monary hypertension (OR=1, 21, P=0.029) and the presence of a paradoxical
septum (OR=37, P<0.001). A hospital stay of more than 8 days was signifi-
cantly associated with mortality (OR=4.14, P=0.006).
Conclusion: A better understanding of predictors of hospital mortality in
pulmonary embolism is used to define a population at high risk witch warrants
more aggressive therapy. These data must be confirmed by prospective
studies.
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Introduction: In recent years, clinical assessment of pretest probability has
become a crucial tool in the diagnostic approach of patients with suspected
pulmonary embolism (PE). Study objective
Study and compare the predictive accuracy of clinical prediction scores:
the Wells score(WS) with the Geneva score(GS) and revised Geneva
score(RGS) in the assessment of pretest probability of PE
Methods: It is a monocentric, retrospective study concerning 150 patients
having diagnosed with deep venous thrombosis(DVT) hospitalized in the
emergency department during the period from January 1997 to December
2008.
Results: The study population consisted of 150 patients diagnosed with
DVT confirmed by lower limb ultrasonographic examination. A total of 34 (
23 %)) patients were diagnosed with PE. The distribution of the patients
according to the groups and the under groups in the three clinical prediction
scores as well as the frequency of PE are summarized in this table below
The comparison of the predictive accuracy of the SW and the SG showed
an area under the ROC curve of 0,889 for the SW and 0,834 for the SG with
a slight superiority of the score of wells. the concordance between these two
scores was moderated (u =0,58 ). The SGR had an inferior concordance
compared to the SW (u =0,4 ) and SG (u =0,278 )
Table – The distribution of the patients according to the groups and the under 
groups in the three clinical prediction scores
Conclusions: In our population the Wells score appeared to be more accu-
rate than the Geneva score and the simplified revised Geneva score. The
impact of this finding in terms of patient outcomes should be investigated in
a prospective study.
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Purpose: High aldosterone levels are associated with vascular injury and
poor outcome after STEMI. We hypothesized that early aldosterone receptor
blockade at admission for primary PCI may improve myocardial perfusion.
Methods: 159 consecutive patients admitted for primary PCI for STEMI
were treated by 200 mg IV potassium canrenoate at presentation. The patients
were randomly matched to 318 patients based on the admission GRACE
score’s deciles. Myocardial blush grade (MBG) was assessed in all patients by
2 operators blinded to the treatment. The outcome of the study was the rate of
MBG 3 after primary PCI. A multivariable conditional logistic regression
model adjusted on abciximab and thienopyridine pre-treatment, and the
symptom to needle time was used to compare cases and controls.
Results: cases and controls were comparable regarding age (63±14 vs
62±14) gender (mal 81 vs 79%), and baseline risk factors. Cases presented
later (7.7±9.5 vs 5.6±5.4, p=NS) and were less often treated by abciximab (75
vs 84%, p<0.05).
TIMI flow grades prior and after primary PCI were comparable between
cases and controls. Based on TIMI flow grade the success rate was compa-
rable between cases and controls (87 vs 90%). MBG 3 rate was significantly
higher in cases than in controls with an adjusted OR 2.23 (95%CI 1.40-3.55).
Figure depicts the distribution of post-PCI MBG among cases and controls.
Conclusions: Early aldosterone blockade on admission for primary PCI is
associated with improved myocardial reperfusion as assessed by MBG. These
findings underscore the vasculoprotective effects of aldosterone blockade
early after STEMI. 
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Purpose: Risk stratification in patients presenting severe heart failure in
the Intensive Care Unit (ICU) with acute decompensation is difficult. The
Interagency Registry for Mechanically Assisted Circulatory Support
(INTERMACS) had defined seven clinical Profiles to describe patients
Clinical 
propability
Wells score 
(N=150) N(%)
Geneva score 
(N=150) N(%)
revised Geneva score 
(N=150) N(%)
low 0 122(81.3) 2(1.4)
moderete 129(86) 26(17.3) 93(62)
high 21(14) 2(1.4) 55(36.6)
p <0.001 <0.001 0.028
Frequency of the PE N(%) N(%) N(%)
low 0 19(16) 2(100)
moderete 19(15) 14(54) 19(19.4)
high 15(71) 1(50) 13(23.6)
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included in its registry. We assessed the INTERMACS (IMCS) classification
in patients admitted in an ICU with cardiogenic shock.
Methods: Consecutive patients with cardiogenic shock on admission who
were admitted in a tertiary hospital ICU. IMCS status was assessed at within
the first 24 hours and 96 hours after admission. Outcomes (bi-ventricular
assist device (BiVAD), heart transplantation (HT) and mortality) were
recorded in hospital and at 3 and 12 months.
Results: The study included 87 patients (median age 60 [IQR:54-69]
years). 41 (47%) patients had IABP and 27 (31%) were on mechanical venti-
lation. At 24 hours after admission, 7 patients (8.04%) with IMCS Profile 1
(critical cardiogenic shock), 18 (20.6%) with IMCS Profile 2 (sliding on ino-
tropes) and 62 (71.3%) with IMCS Profile 3 (dependant on inotropes). Results
are presented in the table.
Conclusion: In patients with cardiogenic shock, the INTERMACS classi-
fication is an easy way to classify patient's risk during the first 24 hours. Evo-
lution of IMCS profiles allows to assess response to treatment over time. It
may present as a useful tool in the ICU to discuss early the best strategies to
manage cardiogenic shocks. 
Table – Results
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The use of drugs is the subject of numerous recommendations. Most of
sudden cardiac deaths (SD) are related to a ventricular fibrillation (VF) and
ischemic heart disease, but some of them are drug-related. The purpose of
study was to evaluate the prevalence of drug-related SD’s and the possible
changes during these past 20 years.
Methods: 239 patients, 181 men, 58 women, aged from 12 to 88 years
(61±15) were admitted after SD resuscitation outside the acute phase of myo-
cardial infarction, 139 before 2000 (group I), 100 between 2000 and 2010
(group II). Clinical data, treatment, electrolytes, echocardiography, Holter
ECG, exercise testing, electrophysiological study (EPS), evaluation of coronary
status and ergonovine test when coronary arteries were normal, were collected.
Results: The causes of resuscitated SD’s did not change significantly
during these 2 periods. The presence or not of heart disease (HD) did not
differ: 34 group I patients (24%) and 34 group II patients (34%) had no
apparent (HD)(NS). Ischemic HD, idiopathic dilated cardiomyopathy, valvular
HD, coronary spasm, various HD’s, preexcitation syndrome or ion channel
disorders were as frequent in group I (42%, 11.5%, 12%, 3%, 3.5%, 4%) as
in group II (34%, 11%, 6%, 4%, 6%, 5%). Drug-related SD’s did not change
during these periods: 38 patients presented a drug-related VT/VF or asystole
with cardiac arrest, 20 (14%) before 2000 and 18 patients (18%) since 2000.
SD was caused by hypokaliema or increase of QT interval or a major conduc-
tion disturbance. HD or abnormal ECG was present in 20 patients. Digoxin,
diuretics, calcium inhibitors, betablockers, antiarrhythmic drugs alone or in
association were the implicated drugs.
Conclusion: Drug-related arrhythmias continue to explain at least 15% of
SD’s. Despite the publication of numerous recommendations on the use of
drugs, the number of fatal events that may be attributed to a cardiovascular
drug did not decrease between the years before 2000 and after 2000. 
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Introduction: An increased risk of malignant arrhythmias may exist following
electrocution and electrocuted patients are routinely hospitalized in intensive care
unit (ICU) for monitoring. The purpose of this study was to evaluate the short-
term incidence of arrhythmias and sudden death in electrocuted patients.
Methods: This monocentric retrospective study included all patients hos-
pitalized between January 2005 and November 2010 in ICU at Cochin hos-
pital (Paris, France).
Results: We enrolled 31 consecutive patients (mean age 33±15 years, 74%
men). Electrocution was due to domestic current (alternating current, 230V single-
phase, 50Hz of frequency) in 65% of cases. Electrocution was a work related acci-
dent in 70% of cases. Superficial burns were observed in 87% of patients. Cardiac
troponin Ic level (normal range <0.04 μg/ml) was found to be elevated in 16% of
patients (mean 0,09±0,03 μg/ml) and creatinine kinase level was found to be
increased in 55% of patients (426±713 UI/l). Electrocardiogram abnormalities
were noticed in 84% of cases (ventricular hypertrophy in 11, incomplete bundle
branch block in 9, diffuse ST-segment elevation in 6, and negative T waves in inf-
erolateral leads in 13). Echocardiography was performed in 6% of patients and
revealed mild septal hypertrophy (mean 13±2 mm) without segmental wall-
motion abnormalities. During a mean ICU stay of 1±0.5 day, none of the patients
presented atrial or ventricular arrythmias nor sudden death. During a mean follow-
up of 30±10 months, 29% of patients were lost and the remaining 71% did not
present physical or psychological sequelae related to electrocution.
Conclusion: In our study, the initial course of all electrocuted patients was
uneventful. These results suggest that systematic hospitalization in ICU may
not be mandatory after electrocution.
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Background: recent improvements in the management of out-of-hospital
cardiac arrest (OHCA) should allow a better prognosis. This study aims at
Best IMC Profile 
within the first 
24 hours
IMCS (n=7)
Profile 1 
IMCS (n=18)
Profile 2
IMCS (n=62)
Profile 3
Ischemic 
myocardiopathy
3(42.9%) 12(66.7%) 28(45.2%)
Median age 
(yr.-IQ)
57(5.5) 62(16) 58(7)
Evolution 
24-96 hours: Died
5 4 1
Evolution 
24-96 hours:
 BiVAD pr HT
1 2 3
Alive without 
BiVAD or HT 
at the 96th hour
1(14%) 12(66.6%) 58(93.5%)
Evolution in ICU 
after the 96th hour
Died 4 4
BiVAD or HT 4 4
Discharged from 
ICU without BiVAD 
or HT
1(14%) 4(22%) 47(75.8%)
3-months 
mortality
n=5(71%) n=12(67%) n=21(34%)*
1-year mortality n=6(86%) n=12(67%) n=27(44%)*
*p values <0.05 Profile 3 vs 2, Profile 3 vs 1
